PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 29, 2026Respiratory Endoscopy0 citationsOpen Access

Complete Atelectasis of Left Lung due to Methotrexate-associated Lymphoproliferative Disorder: A Case Report

HMHiroto MuraoSOSaori OnishiTYToshiyuki Yonezawa

Key Points

  • To illustrate a rare case of complete atelectasis associated with methotrexate-related lymphoproliferative disorder in a patient with rheumatoid arthritis.
  • Evaluation of a 59-year-old man experiencing dyspnea after methotrexate treatment.
  • Imaging via chest computed tomography to identify lung obstruction.
  • Histopathological analysis through trans-bronchial biopsies to confirm diagnosis.
  • Identification of a mass obstructing the left main bronchus leading to complete left lung atelectasis.
  • Positive results for Epstein-Barr virus during histopathological examination.
  • Remission of both tumor and atelectasis following withdrawal of methotrexate.

Abstract

A 59-year-old man who had been treated with methotrexate (MTX) for rheumatoid arthritis was referred to our hospital because of dyspnea. Chest computed tomography revealed a mass obstructing the left main bronchus and complete atelectasis of the left lung. Histopathology of the tumor obtained by trans-bronchial biopsies showed lymphoproliferative disorder (LPD) with positive results for Epstein-Barr virus-encoded small ribonucleic acid in situ hybridization. Withdrawal of MTX resulted in remission of both the tumor and atelectasis, supporting the diagnosis of MTX-associated LPD (MTX-LPD). We herein report a rare case of MTX-LPD with complete atelectasis of a unilateral lung.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Murao et al. (2026) studied this question.

synapsesocial.com/papers/69c8c195de0f0f753b39beb2https://doi.org/10.58585/respend.2025-0060
Ask AI
Helpful
Bookmark
Share
View Full Paper